Serum vascular endothelial growth factor (VEGF) levels in ischemic stroke patients: a systematic review and meta-analysis of case–control studies

@article{SeidkhaniNahal2020SerumVE,
  title={Serum vascular endothelial growth factor (VEGF) levels in ischemic stroke patients: a systematic review and meta-analysis of case–control studies},
  author={Ali Seidkhani-Nahal and Afra Khosravi and Asad Mirzaei and Gholam Basati and Milad Abbasi and Ali Noori-Zadeh},
  journal={Neurological Sciences},
  year={2020},
  volume={42},
  pages={1811 - 1820}
}
Serum VEGF level is regarded to be a biomarker for the diagnosis of stroke. Even though there have been published plethora of original articles describing higher blood VEGF concentrations since the 1970s, however, there is no any meta-analysis report for serum VEGF levels in the field of evidence-based medicine yet. A systematic review was performed by searching the online biomedical databases including retrieving 14 case–control studies including within-article subgroups after fulfilling the… 

Outgrowth Endothelial Cell Conditioned Medium Negates TNF-α-Evoked Cerebral Barrier Damage: A Reverse Translational Research to Explore Mechanisms.

TLDR
This reverse translational study identifies TNF-α as an important mediator of post-ischemic cerebral barrier damage and proposes OEC-CM as a potential vasculoprotective therapeutic strategy by demonstrating its ability to regulate a wide range of mechanisms associated with BBB function.

Study on potential differentially expressed genes in stroke by bioinformatics analysis

TLDR
The findings will contribute to identification of potential biomarkers and novel strategies for the treatment of ischemic stroke, and provide a new strategy for clinical therapy.

Corneal nerve loss in patients with TIA and acute ischemic stroke in relation to circulating markers of inflammation and vascular integrity

TLDR
Larger longitudinal studies are required to determine the association between inflammatory and vascular markers and corneal nerve fiber loss in patients with cerebrovascular disease.

Neovascularization

TLDR
The current knowledge of EPCs in cerebral neovascularization and tissue regeneration after cerebral ischemia and the factors associated with their regenerative function are reviewed to better understand the underlying mechanisms and provide more effective strategies for the use of E PCs in treating ischemic stroke.

Neovascularization and tissue regeneration by endothelial progenitor cells in ischemic stroke

TLDR
The current knowledge of EPCs in cerebral neovascularization and tissue regeneration after cerebral ischemia and the factors associated with their regenerative function are reviewed to better understand the underlying mechanisms and provide more effective strategies for the use of E PCs in treating ischemic stroke.

Non-invasive Urinary Biomarkers in Moyamoya Disease

TLDR
The hypothesis that urinary proteins are useful predictors of the presence of moyamoya disease and may provide a basis for a novel, non-invasive method to identify new disease and monitor known patients following treatment is supported.

References

SHOWING 1-10 OF 37 REFERENCES

Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study

TLDR
Although plasma VEGF value increases immediately after the stroke onset equally in all stroke sub types, its significance in functional outcome may be different among the stroke subtypes.

Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke

TLDR
VEGF and endostatin may mediate EPCs proliferation in the early phase of ischemic stroke, and the circulating EPCS levels can be a predictor of clinical outcome in AIS, according to ROC curve analysis.

Comparison of Mean VEGF-A Expression Between Acute Ischemic Stroke Patients and Non-Ischemic Stroke Subjects

TLDR
Expression of VEGF-A in acute ischemic stroke group was lower when compared with the non-stroke group, and levels were significantly higher in theNon- Stroke group than in the acute group, with p = 0.02.

Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke.

TLDR
VEGF may play an important role in the pathophysiology of acute ischemic stroke and could be of value in future treatment strategies and correlation between stroke severity and VEGF concentration suggests it could be involved in the subsequent repair processes resulting in partial recovery after stroke.

The Janus Face of VEGF in Stroke

TLDR
The present review discusses the multifaceted action of VEGFs in stroke prevention and therapy and suggests that the key to understanding this Janus face of V EGF function in stroke may lie in the timing; the harmful effect of VegFs on vessel integrity is transient.

Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia.

TLDR
In HN33, an immortalized hippocampal neuronal cell line, VEGF reduced cell death associated with an in vitro model of cerebral ischemia: at a maximally effective concentration of 50 ng/ml, V EGF approximately doubled the number of cells surviving after 24 h of hypoxia and glucose deprivation.

Circulating MiRNA-195-5p and -451a in Transient and Acute Ischemic Stroke Patients in an Emergency Department

TLDR
A role for this miRNAs as biomarker in the pathogenesis and prognosis of AIS patients and for the first time also in TIA patients is suggested.

Outcome in Survivors of Middle Cerebral Artery Territory Ischemic Stroke: Can it be predicted?

TLDR
Assessment of functional disability in middle cerebral artery (MCA) territory ischemic stroke patients by applying standard scales for stroke severity, cognitive impairment, disability, dependency and depression shows that disability assessment late in the first week after onset of stroke using National Institutes of health Stroke Scale accurately forecast outcome at one month after onset.

Serum growth factors and neuroprotective surveillance: focus on IGF-1.

TLDR
New evidence strongly suggests that IGF-I, and other blood-borne neurotrophic factors such as Fibroblast Growth Factor (FGF-2) or the neurotrophins, exert a tonic trophic input on brain cells, providing a mechanism for what the authors may refer to as neuroprotective surveillance.

VEGF Protects Brain against Focal Ischemia without Increasing Blood–Brain Permeability When Administered Intracerebroventricularly

TLDR
Single intracerebroventricular injection of VEGF protects brain against ischemia without adversely affecting BBB permeability, and has a relatively long therapeutic time window.